BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 15.10
+0.10 (0.67%)
Aug 10, 2026, 10:19 AM EST
BioSyent Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45.98 | 43.05 | 35.03 | 31.59 | 27.93 | 28.62 | |
Revenue Growth | 20.13% | 22.90% | 10.89% | 13.13% | -2.42% | 28.15% |
Cost of Revenue | 11.19 | 10.09 | 7.17 | 5.99 | 5.07 | 5.98 |
Gross Profit | 34.79 | 32.96 | 27.86 | 25.6 | 22.86 | 22.64 |
Selling, General & Admin | 22.93 | 21.21 | 18.85 | 18.01 | 15.78 | 14.34 |
Research & Development | 0.51 | 0.56 | 0.25 | 0.12 | 0.1 | 0.12 |
Total Operating Expenses | 23.44 | 21.77 | 19.1 | 18.13 | 15.88 | 14.45 |
Operating Income | 11.35 | 11.19 | 8.75 | 7.47 | 6.98 | 8.18 |
Interest Income | -0.87 | -0.89 | -1.09 | -1.13 | -0.53 | -0.16 |
Interest Expense | 0.07 | 0.05 | 0.06 | 0.07 | 0.08 | 0.09 |
Other Non-Operating Income (Expense) | - | - | - | - | - | 0.13 |
Total Non-Operating Income (Expense) | -0.81 | -0.84 | -1.03 | -1.06 | -0.45 | 0.05 |
Pretax Income | 12.16 | 12.03 | 9.78 | 8.53 | 7.43 | 8.38 |
Provision for Income Taxes | 3.12 | 3.02 | 2.51 | 2.07 | 1.97 | 2.1 |
Net Income | 9.04 | 9.01 | 7.27 | 6.46 | 5.46 | 6.28 |
Net Income to Common | 9.04 | 9.01 | 7.27 | 6.46 | 5.46 | 6.28 |
Net Income Growth | 15.54% | 23.96% | 12.54% | 18.35% | -13.11% | 65.51% |
Shares Outstanding (Basic) | 11 | 11 | 12 | 12 | 12 | 13 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 13 | 13 |
Shares Change | -1.57% | -2.55% | -2.98% | -2.95% | -2.57% | -1.70% |
EPS (Basic) | 0.78 | 0.80 | 0.63 | 0.54 | 0.44 | 0.49 |
EPS (Diluted) | 0.78 | 0.78 | 0.62 | 0.53 | 0.43 | 0.49 |
EPS Growth | 16.42% | 27.11% | 16.01% | 22.07% | -10.86% | 68.28% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 12.39 | 8.96 | 8.62 | 5 | 4.9 | 4.59 |
Free Cash Flow Growth | 78.74% | 3.87% | 72.58% | 1.91% | 6.79% | -33.29% |
Free Cash Flow Per Share | 1.07 | 0.78 | 0.73 | 0.41 | 0.39 | 0.36 |
Dividends Per Share | 0.205 | 0.200 | 0.180 | 0.160 | 0.040 | - |
Dividend Growth | 10.81% | 11.11% | 12.50% | 300.00% | - | - |
Gross Margin | 75.67% | 76.57% | 79.52% | 81.03% | 81.85% | 79.10% |
Operating Margin | 24.69% | 26.00% | 24.99% | 23.65% | 25.00% | 28.59% |
Profit Margin | 19.65% | 20.93% | 20.75% | 20.45% | 19.55% | 21.95% |
FCF Margin | 26.94% | 20.80% | 24.61% | 15.81% | 17.55% | 16.04% |
EBITDA | 12.48 | 12.05 | 9.34 | 7.93 | 7.43 | 8.64 |
EBITDA Margin | 27.15% | 27.98% | 26.67% | 25.09% | 26.62% | 30.19% |
EBIT | 11.35 | 11.19 | 8.75 | 7.47 | 6.98 | 8.18 |
EBIT Margin | 24.69% | 26.00% | 24.99% | 23.65% | 25.00% | 28.59% |
Effective Tax Rate | 25.68% | 25.09% | 25.68% | 24.30% | 26.54% | 25.03% |